Partnership with UK cooperative groups
New Collaboration Pathways have been developed jointly between the UK LO and the EORTC HQ in Brussels to address the lack of a single efficient mechanism to explore UK clinical trial collaboration with the EORTC and vice-versa. They provide a high level overview of the key steps involved in determining whether EORTC/UK collaboration is viable, with the aim of obtaining a more timely response. Alongside the pathways a confidentiality framework has been developed to protect against the sharing of study information outside of the collaboration discussions. This framework forms the basis of a “conditions of use” agreement associated with utilising the Collaboration Pathways the details of which are sent on a study-by-study basis.